-
公开(公告)号：US08992432B2
公开(公告)日：2015-03-31
申请号：US13279030
申请日：2011-10-21
IPC分类号： A61B5/02 , A61N1/39 , A61B5/024 , A61B5/0205 , A61N1/365
CPC分类号： A61N1/36557 , A61B5/0059 , A61B5/02 , A61B5/0205 , A61B5/02108 , A61B5/02416 , A61B5/02427 , A61B5/082 , A61B5/4836 , A61B5/4848 , A61B5/746 , A61B8/06 , A61B8/488 , A61N1/3625 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates optical characteristics of light transmitted into a patient to ascertain physiological signals, such as pulsatile changes in general blood volume proximate a light detector module. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US08532766B2
公开(公告)日：2013-09-10
申请号：US13267783
申请日：2011-10-06
申请人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
发明人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
IPC分类号： A61N1/39
CPC分类号： A61N1/3925 , A61B5/0464 , A61B5/0535 , A61B5/0538 , A61B5/7264 , A61B7/00 , A61B7/04 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US20120035485A1
公开(公告)日：2012-02-09
申请号：US13279030
申请日：2011-10-21
IPC分类号： A61B5/024
CPC分类号： A61N1/36557 , A61B5/0059 , A61B5/02 , A61B5/0205 , A61B5/02108 , A61B5/02416 , A61B5/02427 , A61B5/082 , A61B5/4836 , A61B5/4848 , A61B5/746 , A61B8/06 , A61B8/488 , A61N1/3625 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates optical characteristics of light transmitted into a patient to ascertain physiological signals, such as pulsatile changes in general blood volume proximate a light detector module. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US20080208273A1
公开(公告)日：2008-08-28
申请号：US12105207
申请日：2008-04-17
CPC分类号： A61N1/36557 , A61B5/0059 , A61B5/02 , A61B5/0205 , A61B5/02108 , A61B5/02416 , A61B5/02427 , A61B5/082 , A61B5/4836 , A61B5/4848 , A61B5/746 , A61B8/06 , A61B8/488 , A61N1/3625 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates optical characteristics of light transmitted into a patient to ascertain physiological signals, such as pulsatile changes in general blood volume proximate a light detector module. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
摘要翻译： 通过评估患者的生理信号来确定患者心脏脉搏的存在。 在一个实施例中，医疗装置评估透射到患者中的光的光学特性，以确定生理信号，例如靠近光检测器模块的一般血液体积的脉动变化。 使用这些特征，医疗装置确定患者心脏脉搏是否存在。 除了处于无脉动状态之外，医疗装置还可以被配置为报告患者是否处于VF，VT，心搏停止或PEA状态，并且提示不同的疗法，例如胸部按压，救援呼吸，除颤和 PEA特异性电疗，取决于生理信号的分析。 进一步提供使用起搏刺激自动捕获心脏脉搏。
-
公开(公告)号：US08591425B2
公开(公告)日：2013-11-26
申请号：US13279048
申请日：2011-10-21
IPC分类号： A61B5/02
CPC分类号： A61N1/36557 , A61B5/0059 , A61B5/02 , A61B5/0205 , A61B5/02108 , A61B5/02416 , A61B5/02427 , A61B5/082 , A61B5/4836 , A61B5/4848 , A61B5/746 , A61B8/06 , A61B8/488 , A61N1/3625 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates optical characteristics of light transmitted into a patient to ascertain physiological signals, such as pulsatile changes in general blood volume proximate a light detector module. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US20120302896A1
公开(公告)日：2012-11-29
申请号：US13569147
申请日：2012-08-07
申请人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
发明人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
CPC分类号： A61N1/3925 , A61B5/0464 , A61B5/0535 , A61B5/0538 , A61B5/7264 , A61B7/00 , A61B7/04 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US20120029584A1
公开(公告)日：2012-02-02
申请号：US13272733
申请日：2011-10-13
申请人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
发明人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
CPC分类号： A61N1/3925 , A61B5/0464 , A61B5/0535 , A61B5/0538 , A61B5/7264 , A61B7/00 , A61B7/04 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
-
公开(公告)号：US5477858A
公开(公告)日：1995-12-26
申请号：US728830
申请日：1991-07-09
申请人： Paul R. Norris , John Folline , Richard H. Chesarek , Michael J. Veraya , James R. Chekerylla , Richard A. Revell , Thomas R. Clary , Richard K. Johnson , Lee D. Dunbar , David R. Axness , John C. Lazenby , Donald R. Gardner , William E. Crone , W. Gerrit Barrere , Charles C. Myrick , Bruce M. Pirie , Leonard D. Seader , Louis A. Heaton , David M. Polakowski , Brian J. Sargent
发明人： Paul R. Norris , John Folline , Richard H. Chesarek , Michael J. Veraya , James R. Chekerylla , Richard A. Revell , Thomas R. Clary , Richard K. Johnson , Lee D. Dunbar , David R. Axness , John C. Lazenby , Donald R. Gardner , William E. Crone , W. Gerrit Barrere , Charles C. Myrick , Bruce M. Pirie , Leonard D. Seader , Louis A. Heaton , David M. Polakowski , Brian J. Sargent
CPC分类号： G10K11/346 , A61B8/467 , G01S15/8918 , G01S15/8981 , G01S15/8988 , G01S15/899 , G01S7/52026 , G01S7/52033 , G01S7/52034 , G01S7/52069 , G01S7/52073 , G01S7/52084 , G06F19/3406 , G10K11/002 , G10K11/02 , A61B8/06 , A61B8/4281 , G06F19/3412
摘要： An ultrasound imaging system is provided which produces gray scale images of the anatomy simultaneous with Doppler signal processing so as to provide a single real-time image that shows not only the vascular anatomy and surrounding tissue but also flow events in the vascular compartment. A phased linear array having near-continuous focus over the scanning field provides high resolution and very small Doppler sample volumes. The system tests incoming signals from throughout the scanning field for amplitude, phase and frequency so as to determine B-mode data, motion presence and direction, and echo source velocity.
摘要翻译： 提供超声成像系统，其与多普勒信号处理同时产生解剖结构的灰度图像，以便提供不仅显示血管解剖结构和周围组织而且还显示血管隔室中的流动事件的单个实时图像。 在扫描场上具有近连续焦点的相控线性阵列提供高分辨率和非常小的多普勒样本体积。 该系统测量来自整个扫描场的入射信号的幅度，相位和频率，以便确定B模式数据，运动存在和方向以及回波源速度。
-
公开(公告)号：US20140012144A1
公开(公告)日：2014-01-09
申请号：US13937507
申请日：2013-07-09
申请人： William E. CRONE
发明人： William E. CRONE
CPC分类号： A61B5/02028 , A61B5/02416 , A61B5/0261 , A61B5/0402 , A61B5/046 , A61B5/11 , A61B5/1102 , A61B5/746 , A61B7/00 , A61B2562/0204 , A61B2562/0219
摘要： According to some embodiments, a system for detecting a perfusion index of a cardiac pulse includes a first sensor that senses a first physiological or environmental parameter of a human patient core, a second sensor that senses a second physiological or environmental parameter of the human patient core, a processor that, responsive to the first and second sensed parameters, determines a perfusion index ranging from 0 to 10 that reflects inadequate, marginal, or adequate blood perfusion to the core of the human patient torso, and an indicator that provides a discernible indication of the perfusion index. A method of detecting as perfusion index of a cardiac pulse responsive to sensing first and second physiological or environmental parameters of a human patient core is also disclosed.
摘要翻译： 根据一些实施例，用于检测心脏脉搏的灌注指数的系统包括感测人患者核心的第一生理或环境参数的第一传感器，感测人患者核心的第二生理或环境参数的第二传感器 ，响应于第一和第二感测参数的处理器确定反映不足，边缘或足够的血液灌注到人类患者躯干的核心的0至10的灌注指数，以及提供可辨别的指示的指示器 的灌注指数。 还公开了一种检测响应于感测人患者核心的第一和第二生理或环境参数的心脏脉搏的灌注指数的方法。
-
10.发明授权Pulse detection apparatus, software, and methods using patient physiological signals 有权脉搏检测装置，软件和使用患者生理信号的方法公开(公告)号：US08239024B2
公开(公告)日：2012-08-07
申请号：US13032250
申请日：2011-02-22
申请人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
发明人： Tae H. Joo , Ronald E. Stickney , Cynthia P. Jayne , Paula Lank , Patricia O'Hearn , David R. Hampton , James W. Taylor , William E. Crone , Daniel Yerkovich
IPC分类号： A61N1/365
CPC分类号： A61N1/3925 , A61B5/0464 , A61B5/0535 , A61B5/0538 , A61B5/7264 , A61B7/00 , A61B7/04 , A61N1/365 , A61N1/39 , A61N1/3987
摘要： The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.
摘要翻译： 通过评估患者的生理信号来确定患者心脏脉搏的存在。 在一个实施例中，医疗设备评估两个或更多个不同的生理信号，例如心电图（PCG）信号，心电图（ECG）信号，患者阻抗信号，压电信号和加速度计信号，用于指示存在心脏脉搏的特征。 使用这些特征，医疗装置确定患者心脏脉搏是否存在。 除了处于无脉动状态之外，医疗装置还可以被配置为报告患者是否处于VF，VT，心搏停止或PEA状态，并且提示不同的疗法，例如胸部按压，救援呼吸，除颤和 PEA特异性电疗，取决于生理信号的分析。 进一步提供使用起搏刺激自动捕获心脏脉搏。
-
-
-
-
-
-
-
-
-
搜索结果
20 条记录 (耗时 0.041 秒)
